María del Mar Maldonado

National Institutes of Health

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Targeting Rac and Cdc42 GEFs in Metastatic Cancer”.

Targeting Rac and Cdc42 GEFs in Metastatic Cancer

Frontiers in Cell and Developmental Biology(2020)10.3389/fcell.2020.00201

N/A

0.721DataRank · unranked

121 citations

Julia I. Medina, Luis Velázquez, Suranganie Dharmawardhane, María del Mar Maldonado

Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03496-2

N/A

0.561DataRank · unranked

41 citations

Jeffrey Schlom, Duane H. Hamilton, María del Mar Maldonado

Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-1192

N/A

0.301DataRank · unranked

6 citations

María del Mar Maldonado, Jeffrey Schlom, Duane H. Hamilton, Maria Gracia-Hernandez

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

BMC Cancer(2021)10.1186/s12885-021-08366-7

N/A

0DataRank · unranked

20 citations

María del Mar Maldonado, Julia Medina‐Velázquez, Angel Luis Troche‐Torres, Luis Velázquez, Nilmary Grafals‐Ruiz +2 more

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice

Pharmaceutics(2020)10.3390/pharmaceutics12100975

N/A

0DataRank · unranked

11 citations

María del Mar Maldonado, Matilde Merino‐Sanjuán, Ailed Cruz‐Collazo, Jean F. Ruiz-Calderón, Víctor Mangas‐Sanjuán +3 more

Rac Inhibition As A Novel Therapeutic Strategy for EGFR/HER2 Targeted Therapy Resistant Breast Cancer

Research Square(2020)10.21203/rs.3.rs-86620/v1

N/A

0DataRank · unranked

0 citations

María del Mar Maldonado, Julia Medina‐Velázquez, Angel Luis Troche‐Torres, Luis Velazquez‐Vega, Nilmary Grafals‐Ruiz +2 more

Data from Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer

(2023)10.1158/1535-7163.c.6543291.v1

N/A

0DataRank · unranked

0 citations

Jean F. Ruiz-Calderón, Hector Picon, Luis D. Borrero-García, Irmaris Lopez, Linette Castillo‐Pichardo +8 more

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011378

N/A

0DataRank · unranked

7 citations

Maria Gracia-Hernandez, Loc Le, Masafumi Iida, James L. Gulley, Renee N. Donahue +4 more

Data from Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer

(2023)10.1158/1535-7163.c.6543291

N/A

0DataRank · unranked

0 citations

Jean F. Ruiz-Calderón, Hector Picon, Luis D. Borrero-García, Irmaris Lopez, Linette Castillo‐Pichardo +8 more